PT981365E - Leptina como inibidor da proliferacao de celulas tumorais - Google Patents

Leptina como inibidor da proliferacao de celulas tumorais

Info

Publication number
PT981365E
PT981365E PT98917580T PT98917580T PT981365E PT 981365 E PT981365 E PT 981365E PT 98917580 T PT98917580 T PT 98917580T PT 98917580 T PT98917580 T PT 98917580T PT 981365 E PT981365 E PT 981365E
Authority
PT
Portugal
Prior art keywords
leptina
inhibitor
cell proliferation
tumor cell
tumor
Prior art date
Application number
PT98917580T
Other languages
English (en)
Inventor
Barkan Dalit
Cohen Batya
Rubinstein Menachem
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of PT981365E publication Critical patent/PT981365E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2264Obesity-gene products, e.g. leptin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98917580T 1997-04-29 1998-04-26 Leptina como inibidor da proliferacao de celulas tumorais PT981365E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12073397A IL120733A0 (en) 1997-04-29 1997-04-29 Leptin as an inhibitor of cell proliferation

Publications (1)

Publication Number Publication Date
PT981365E true PT981365E (pt) 2005-03-31

Family

ID=11070075

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98917580T PT981365E (pt) 1997-04-29 1998-04-26 Leptina como inibidor da proliferacao de celulas tumorais

Country Status (26)

Country Link
US (1) US7109159B1 (pt)
EP (1) EP0981365B1 (pt)
JP (1) JP4330662B2 (pt)
KR (1) KR100507731B1 (pt)
CN (1) CN1168497C (pt)
AR (1) AR012626A1 (pt)
AT (1) ATE283702T1 (pt)
AU (1) AU742927B2 (pt)
BG (1) BG63490B1 (pt)
CA (1) CA2288238A1 (pt)
CZ (1) CZ299872B6 (pt)
DE (1) DE69827942T2 (pt)
EA (1) EA002353B1 (pt)
EE (1) EE04801B1 (pt)
ES (1) ES2232944T3 (pt)
HK (1) HK1028350A1 (pt)
HU (1) HUP0002427A3 (pt)
IL (2) IL120733A0 (pt)
NO (1) NO322304B1 (pt)
NZ (1) NZ500589A (pt)
PL (1) PL195275B1 (pt)
PT (1) PT981365E (pt)
SK (1) SK284848B6 (pt)
UA (1) UA66793C2 (pt)
WO (1) WO1998048831A1 (pt)
ZA (1) ZA983608B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
IL132312A0 (en) * 1999-09-05 2001-03-19 Yeda Res & Dev Use of leptin in inhibition of endothelial cell proliferation
EP2422807A3 (en) 2004-02-11 2012-05-30 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
US7863240B2 (en) * 2004-10-08 2011-01-04 Enzo Therapeutics, Inc. Methods and uses of leptin in hepatocellular carcinoma
US20090286723A1 (en) 2005-02-11 2009-11-19 Amylin Pharmaceuticals, Inc. Hybrid Polypeptides with Selectable Properties
KR20070115947A (ko) 2005-02-11 2007-12-06 아밀린 파마슈티칼스, 인크. 선택가능한 특성들을 가지는 gip 유사체 및 하이브리드폴리펩타이드
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
US8716220B2 (en) * 2005-09-07 2014-05-06 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8642543B2 (en) * 2005-09-07 2014-02-04 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
CA2712606A1 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
TWI752920B (zh) 2015-10-12 2022-01-21 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
AU2017359439A1 (en) 2016-11-08 2019-05-23 Regeneron Pharmaceuticals, Inc. Antigen-binding proteins that antagonize leptin receptor
AU2018390811A1 (en) 2017-12-18 2020-07-02 Regeneron Pharmaceuticals, Inc. Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
EP3773713A1 (en) 2018-04-06 2021-02-17 Regeneron Pharmaceuticals, Inc. A leptin receptor agonist antibody for use in treating a metabolic dysfunction or hypoleptinemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002004A2 (en) * 1995-06-30 1997-01-23 Eli Lilly And Company Methods for treating diabetes
EP0764722A2 (en) * 1995-09-19 1997-03-26 Eli Lilly And Company DNA encoding primate leptins as medicinal proteins
EP0892849B1 (en) * 1996-01-23 2006-03-15 Indevus Pharmaceuticals, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development

Also Published As

Publication number Publication date
AU7076298A (en) 1998-11-24
ZA983608B (en) 1998-11-02
DE69827942T2 (de) 2005-12-08
ATE283702T1 (de) 2004-12-15
AR012626A1 (es) 2000-11-08
EP0981365B1 (en) 2004-12-01
HUP0002427A2 (hu) 2000-12-28
IL120733A0 (en) 1997-08-14
NO995267D0 (no) 1999-10-28
NZ500589A (en) 2001-03-30
HK1028350A1 (en) 2001-02-16
KR20010012080A (ko) 2001-02-15
CA2288238A1 (en) 1998-11-05
CZ384899A3 (cs) 2000-06-14
BG103832A (en) 2000-10-31
PL195275B1 (pl) 2007-08-31
US7109159B1 (en) 2006-09-19
EE04801B1 (et) 2007-04-16
BG63490B1 (bg) 2002-03-29
JP4330662B2 (ja) 2009-09-16
NO322304B1 (no) 2006-09-11
DE69827942D1 (de) 2005-01-05
UA66793C2 (uk) 2004-06-15
CN1261802A (zh) 2000-08-02
AU742927B2 (en) 2002-01-17
NO995267L (no) 1999-12-28
JP2001524968A (ja) 2001-12-04
ES2232944T3 (es) 2005-06-01
CZ299872B6 (cs) 2008-12-17
EP0981365A1 (en) 2000-03-01
IL132633A (en) 2007-07-04
PL336582A1 (en) 2000-07-03
SK147199A3 (en) 2000-06-12
WO1998048831A1 (en) 1998-11-05
SK284848B6 (sk) 2006-01-05
KR100507731B1 (ko) 2005-08-10
EA002353B1 (ru) 2002-04-25
EE9900510A (et) 2000-06-15
HUP0002427A3 (en) 2003-02-28
CN1168497C (zh) 2004-09-29
EA199900981A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
PT981365E (pt) Leptina como inibidor da proliferacao de celulas tumorais
CU23063A3 (es) Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
PT1001934E (pt) Compostos de indole como inibidores de cox-2
PT818448E (pt) Cicloalcano-piridinas como inibidores da cetp
PT1042287E (pt) Derivados de indole como inibidores do factor xa
ID24612A (id) Hidrogenolisis gliserol
ATE260248T1 (de) Zellproliferation inhibitoren
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
BR9702328A (pt) Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina
PT1189907E (pt) Tienopirimidinas como inibidores da fosfodiesterase
NO20004579D0 (no) Substituerte bisindolymaleimider for inhibering av celle- proliferering
EE03871B1 (et) Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid
PT1153015E (pt) Pirimidina-2,4,6-trionas uteis como inibidores de metaloproteinases matriciais
BR9609153A (pt) Derivados de estiril-benzimidazol como inibidores da proliferação de celula de musculo liso
PL337031A1 (en) Cyanoguanidines as inhibitors of cell proliferation
FI973720A (fi) Rypsin Agrobacterium-välitteinen transformaatio
PT1121349E (pt) Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta
DE69805678D1 (de) Selbst-stabilisierende Kathode
DE59811892D1 (de) Elektrostimulator
PT1077945E (pt) Isoquinolinas como inibidores de uroquinase
BR9608976A (pt) Acrilonitrilas diheterocíclicas como inibidoras de proliferação de células de musculos lisos
PT830344E (pt) Derivados de benzimidazole 2-substituido como inibidores da proliferacao de celulas musculares lisas
IL132633A0 (en) Leptin as an inhibitor of tumor cell proliferation
SI0981365T1 (en) Leptin as an inhibitor of tumor cell proliferation